Africa Deep Brain Stimulation Market Industry Trends and Forecast to 2034: Segmented by (Product, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
Africa · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$22.0 MnPlaceholder estimate
Estimate 2025$24.3 Mn1.5% of the global market
Projected 2034$59.1 Mn 143.6%Adds $34.8 Mn over 9 forecast years
CAGR 2025–203410.4%Faster than 51% of 173 Medical Devices markets here
Key players5
Africa is 1.46% of the global market.
Among regions, the largest is North America at $928.7 Mn.
Fastest growing: Africa (this report) at 10.4% a year.
Africa ranks 6th of 6 by size among regions.
Market size projection
Africa
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
Value added each year
$34.8 Mn total, 2026–2034
Year-by-year market size, 2024–2034
Deep Brain Stimulation Market market size by year, Africa
Year
Market size
Change that year
Since 2025
2024 (estimate)
$22.0 Mn
—
—
2025 (base)
$24.3 Mn
+$2.3 Mn
—
2026 (forecast)
$26.8 Mn
+$2.5 Mn
+10.4%
2027 (forecast)
$29.6 Mn
+$2.8 Mn
+21.9%
2028 (forecast)
$32.6 Mn
+$3.1 Mn
+34.6%
2029 (forecast)
$36.0 Mn
+$3.4 Mn
+48.6%
2030 (forecast)
$39.8 Mn
+$3.7 Mn
+64%
2031 (forecast)
$43.9 Mn
+$4.1 Mn
+81.1%
2032 (forecast)
$48.5 Mn
+$4.6 Mn
+99.9%
2033 (forecast)
$53.5 Mn
+$5.0 Mn
+120.7%
2034 (forecast)
$59.1 Mn
+$5.6 Mn
+143.6%
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
1 in AfricaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The Africa Deep Brain Stimulation Market Analysis Executive Summary
Deep brain stimulation places thin wires in the brain connected to a pacemaker-like device, to treat Parkinson's, tremor and other conditions.
Key segments of the deep Brain Stimulation market include product (Single-Channel, Dual-Channel and Rechargeable) and indication (Parkinson's, Essential Tremor and Dystonia).
Africa Deep Brain Stimulation market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
Africa Deep Brain Stimulation Market Dynamics
Market Growth Drivers
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the deep Brain Stimulation market.
Opportunity
Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the deep Brain Stimulation market strong room to grow.
Market Restraints
Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the deep Brain Stimulation market.
Competitive Landscape for Deep Brain Stimulation Market in Africa
The deep Brain Stimulation market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Deep Brain Stimulation Market in Africa
Deep Brain Stimulation in Africa: rules, payment and research
The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products.[1] In some of the countries we cover here, medical devices are regulated by EDA (Egypt)[2], PPB (Kenya)[3] and SAHPRA (South Africa)[4]. How care is paid for in some of these countries: universal health insurance (Egypt)[5], the SHA (Kenya)[6] and planned National Health Insurance (South Africa)[7]. ClinicalTrials.gov lists 1 study on Deep Brain Stimulation that is recruiting, active or about to start in Africa.[8]
[8]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.
Policy changes and Reimbursement scenario
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how deep Brain Stimulation products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Africa.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Product
4.2 By Indication
4.3 By End User
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 Medtronic
7.2 Boston Scientific
7.3 Abbott Laboratories
7.4 Newronika
7.5 SceneRay
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The deep Brain Stimulation market can be segmented based on various criteria, including product, indication and end user. Here's a breakdown of the market segmentation
What doctors and scientists are doing in Deep Brain Stimulation right now, from free public sources.
Clinical trials
1 active trial in Egypt, South Africa, Kenya, Nigeria, Ethiopia, DR Congo, Uganda, Tanzania, Niger, Mozambique, Sudan, Malawi, Zambia, Mali, Burkina Faso, Ghana and Morocco
Recruiting, about to start, or running now. Counted across the 17 countries we report on in Africa.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov.
Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
How big is the Deep Brain Stimulation market in Africa?
Placeholder estimate: about $24.3 Mn in 2025, rising to about $59.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Deep Brain Stimulation market in Africa growing?
Placeholder estimate: about 10.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Deep Brain Stimulation market report cover?
The report splits the market by product (Single-Channel, Dual-Channel, Rechargeable, Adaptive Systems), indication (Parkinson's, Essential Tremor, Dystonia, Epilepsy and more) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Deep Brain Stimulation market?
Key players include Medtronic, Boston Scientific Corporation, Abbott Laboratories, Newronika and SceneRay.
What is driving the Deep Brain Stimulation market?
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the deep Brain Stimulation market.
Who regulates Deep Brain Stimulation in Africa?
The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products. Source: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
How many clinical trials on Deep Brain Stimulation are running in Africa?
1 study is recruiting, active or about to start in Africa, counted across the 17 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Africa. Retrieved 12 Nov 2026.
How much research is published on Deep Brain Stimulation?
PubMed lists 7,259 papers on Deep Brain Stimulation added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.